By a News Reporter-Staff News Editor at Biotech Week -- Janssen Research & Development, LLC (" Janssen ") announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA(®) (ibrutinib) to the U.S. Food and Drug Administration ... 4 Traders, 21 hours ago
Imbruvica receives European approval for two forms of blood cancer - PharmaBiz, 1 week ago
European Commission approves ibrutinib in two forms of blood cancer - Ecancer Medicalscience, 1 week ago
More from: Reuters UK, Stock Nod...and 74 other sources
3 images for "Ibrutinib"
SCHAFFHAUSEN, Suiza, 20 de octubre de 2014 /PRNewswire/ --Pharmacyclics Switzerland GmbH, una filial de Pharmacyclics, Inc. (NASDAQ: PCYC ), ha anunciado hoy que la Comisión Europea (CE) ha concedido una autorización de marketing para IMBRUVICA ...PR Newswire, 1 week ago La Comisión Europea aprueba IMBRUVICA para dos cánceres sanguíneos PR Newswire, 1 week ago
New Chronic Lymphocytic Leukemia Findings Has Been Reported by Investigators at Pharmacyclics Inc. (Ibrutinib inhibits BCR and NF-kappa B signaling...
New Chronic Lymphocytic Leukemia Findings Has Been Reported by Investigators at Pharmacyclics Inc. (Ibrutinib inhibits BCR and NF-kappa B signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL) By a News ...4 Traders, 22 hours ago VIDEO: Are chemo-free regimens possible for CLL? Oncology Report, 1 month ago Data from Pharmacyclics Inc. Advance Knowledge in Chronic Lymphocytic Leukemia (Kinetics of CLL cells in tissues and blood during therapy with the... 4 Traders, 22 hours ago Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician Journal of Clinical Oncology, 3 weeks ago
Bristol-Myers Squibb Company (NYSE:BMY), Pharmacyclics, Inc. (NASDAQ:PCYC), and Janssen Research & Development, LLC announced today they have entered into a clinical trial collaboration agreement to evaluate the safety, tolerability and preliminary ...American Journal of Managed Care, 2 weeks ago Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration Technology Networks, 2 weeks ago Bristol-Myers Squibb Posts Third Quarter Results Individual.com, 1 day ago Bristol-Myers Squibb Releases 3Q 2014 Financial Results Individual.com, 1 day ago
Oncology Times: doi: 10.1097/01.COT.0000454180.31698.23 News SELINA CHEN-KIANG, PHD Image Tools Genomic analyses of tumor and healthy tissue from patients with mantle cell lymphoma (MCLs) that do not respond to ...Oncology Times, 1 month ago John Byrd Joins OT as Clinical Advisory Editor Oncology Times, 1 month ago
Study identifies potential drug combination for mantle cell lymphoma and chronic lymphocytic leukaemia
Using the molecularly targeted drug ibrutinib (Imbruvica) together with the investigational anticancer agent ABT-199 may improve outcomes for patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), according to preclinical ...Ecancer Medicalscience, 1 month ago
In 2020, orphan drugs are expected to account for 19% of the total share of prescription drug sales excluding generics, reaching $176 billion in annual sales, according to the new EvaluatePharma Orphan Drug Report 2014 from market intelligence firm ...Pharma Letter, 1 hour ago
The non-Hodgkin lymphoma (NHL) market will be worth $9.2 billion by 2020, according to new research. This is up from $5.6 billion in 2013 at a modest compound annual growth rate (CAGR) of 7.4%. This growth will be driven by the expected launch of ...Pharma Letter, 21 hours ago NHL Market (Non-Hodgkin Lymphoma Therapeutics) Worth $9.2 Billion by 2020 Wall Street Select, 1 day ago APAC NHL Treatment Market to Reach US$1.7B by 2020 PharmaAsia, 1 month ago Japan's Non-Hodgkin Lymphoma Market to Top $1 Billion by 2020 Pharmaceutical Executive, 1 month ago
In a report published Monday, H.C. Wainwright analyst Reni Benjamin initiated coverage on TG Therapeutics (NASDAQ: TGTX) with a Buy rating and $17.00 price target. In the report, H.C. Wainwright noted, We are initiating coverage of TG Therapeutics ...Benzinga.com, 3 days ago
on your WebpageAdd Widget >Get your members hooked!